SCYNEXIS Inc./ US8112922005 /
07/06/2024 7:57:16 | Diferencia -0.0340 | Volumen | Bid10:19:03 | Ask10:19:03 | Máximo del día | Price Change Band |
---|---|---|---|---|---|---|
2.1060EUR | -1.59% | - Volumen de negocios: - |
2.0640Volumen de oferta: 1,300 | 2.1440Tamaño/ Volumen/ Formato de Ask: 1,300 | 2.1060 | 2.1060 |
GlobeNewswire
10:38
Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improveme...
GlobeNewswire
10:30
Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsenin...
GlobeNewswire
10:11
AMERICAN SALARS FILES NI 43-101 TECHNICAL REPORT ON BLACKROCK SOUTH LITHIUM BRINE PROJECT
GlobeNewswire
9:16
Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens
GlobeNewswire
9:11
Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options
GlobeNewswire
8:07
Hitachi Energy to invest additional $4.5 billion by 2027 to accelerate the clean energy transition
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página